Skip to content

Is Prolonged Period of Prone Position Effective and Safe in Mechanically Ventilated Patients With SARS-COV-2?

Is Prolonged Period of Prone Position Effective and Safe in Mechanically Ventilated Patients With SARS-COV-2? A Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05109624
Enrollment
52
Registered
2021-11-05
Start date
2021-10-01
Completion date
2022-01-01
Last updated
2022-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 Acute Respiratory Distress Syndrome

Brief summary

the aim of the study is to assess safety and efficacy of prone position ventilation beyond the usual 16 hrs in patients with SARS-COV-2

Interventions

PROCEDUREprolonged prone position ventilation

patients mechanically ventilated with SARS COV 2 will be subjected to a longer than usual period of prone position ventilation

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* \- American Society of Anesthesiologists (ASA) physical status II- III. * Sex (male and females). * Age 18 -80 years. * Sever adult respiratory distress (ARDS) (defined as a PaO2:FiO2 ratio of \<150 mm Hg, with a fraction of inspired oxygen (FiO2) of ≥0.6, a positive end expiratory pressure (PEEP) of ≥5 CmH2O, and a tidal volume of 6 ml/Kg of predicted body weight * mechanical ventilation for less than 36 hours

Exclusion criteria

* \- Contraindication for prone positioning * increased intracranial tension. * face trauma or surgery. * Recent Deep venous thrombosis * Unstable spine, femur, or pelvic fractures * Mean arterial pressure \< 65 mm Hg * Pregnant women * Pneumothorax * Prone positioning before inclusion * Those returned to supine position before completing the session time

Design outcomes

Primary

MeasureTime frameDescription
rate of successful weaning28 dayshow many patients successfully extubated, hospital survival, ICU stay
Incidence of complications28 daysIncidence of facial edema, pressure wounds, lines disconnections, hemodynamic instability

Secondary

MeasureTime frameDescription
Efficacy of oxygenation28 daysmean value of change in PaO2/FiO2 ratio and static lung compliance before and after 3 successive proning cycles

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026